NASDAQ:RDNT RadNet - RDNT Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $23.35 +0.21 (+0.91%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$22.70▼$23.4950-Day Range$20.00▼$25.0752-Week Range$12.03▼$25.78Volume175,809 shsAverage Volume339,084 shsMarket Capitalization$1.35 billionP/E Ratio137.35Dividend YieldN/APrice Target$30.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability RadNet MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside28.5% Upside$30.00 Price TargetShort InterestHealthy2.58% of Float Sold ShortDividend StrengthN/ASustainability-0.52Upright™ Environmental ScoreNews Sentiment0.52Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth35.29%From $0.34 to $0.46 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.70 out of 5 starsMedical Sector75th out of 1,005 stocksMedical Laboratories Industry2nd out of 26 stocks 3.5 Analyst's Opinion Consensus RatingRadNet has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $30.00, RadNet has a forecasted upside of 28.5% from its current price of $23.35.Amount of Analyst CoverageRadNet has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.58% of the float of RadNet has been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in RadNet has recently decreased by 5.11%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldRadNet does not currently pay a dividend.Dividend GrowthRadNet does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRadNet has received a 72.34% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Mammography services ", "Nuclear medicine imaging services", and "MRI services" products. See details.Environmental SustainabilityThe Environmental Impact score for RadNet is -0.52. Previous Next 2.5 News and Social Media Coverage News SentimentRadNet has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for RadNet this week, compared to 1 article on an average week.Search Interest4 people have searched for RDNT on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RadNet insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.10% of the stock of RadNet is held by insiders.Percentage Held by Institutions68.27% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for RadNet are expected to grow by 35.29% in the coming year, from $0.34 to $0.46 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RadNet is 137.35, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 114.64.Price to Earnings Ratio vs. SectorThe P/E ratio of RadNet is 137.35, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 85.69.Price to Book Value per Share RatioRadNet has a P/B Ratio of 2.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About RadNet (NASDAQ:RDNT) StockRadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The firm offers magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures. RadNet was founded by Howard G. Berger in 1980 and is headquartered in Los Angeles, CA.Read More Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address RDNT Stock News HeadlinesMarch 23, 2023 | finance.yahoo.comThere Are Reasons To Feel Uneasy About RadNet's (NASDAQ:RDNT) Returns On CapitalMarch 21, 2023 | finance.yahoo.comRadNet, Inc. to Present at the Sidoti & Company 2023 Virtual Spring Investor Conference on Wednesday, March 22ndMarch 25, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. March 20, 2023 | finance.yahoo.comWhy Fast-paced Mover RadNet (RDNT) Is a Great Choice for Value InvestorsMarch 13, 2023 | finance.yahoo.comRadNet, Inc. to Present at the Barclays Global Healthcare Conference on Thursday, March 16thMarch 9, 2023 | finance.yahoo.comAre Investors Undervaluing RadNet (RDNT) Right Now?March 6, 2023 | finance.yahoo.comRadNet, Inc. to Present at the 43rd Annual Cowen & Company Healthcare Conference on Tuesday, March 7thMarch 3, 2023 | finance.yahoo.comRadNet Full Year 2022 Earnings: Revenues Beat Expectations, EPS LagsMarch 25, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. February 28, 2023 | finance.yahoo.comRadNet (RDNT) Misses Q4 Earnings EstimatesFebruary 13, 2023 | thestreet.comRadNet Stock Gaps Down On Today's Open (RDNT)February 12, 2023 | finance.yahoo.comRadNet, Inc. (RDNT) Stock Historical Prices & Data - Yahoo FinanceFebruary 9, 2023 | finance.yahoo.comUPDATE - RadNet, Inc. Announces Date of its Fourth Quarter 2022 Financial Results Conference CallFebruary 9, 2023 | finance.yahoo.comRadNet, Inc. Announces Date of its Fourth Quarter 2022 Financial Results Conference CallFebruary 8, 2023 | finance.yahoo.comRadNet Launches the Enhanced Breast Cancer Detection Program, Providing Women in New York and New Jersey a New State-of-the-Art Solution Powered by Artificial IntelligenceFebruary 6, 2023 | finance.yahoo.comRadiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women a New State-of-the-Art Solution Powered by Artificial IntelligenceDecember 19, 2022 | finance.yahoo.comRadNet’s Artificial Intelligence Subsidiary, DeepHealth, Announces FDA Clearance of its Third AI Mammography ProductDecember 18, 2022 | seekingalpha.comRadNet: Defensive Macro-Positioning Increases Attractiveness, Retain BuyDecember 8, 2022 | finance.yahoo.comIs RadNet, Inc.'s (NASDAQ:RDNT) ROE Of 6.5% Concerning?December 6, 2022 | finance.yahoo.comRadNet, Inc. to Present at the Sidoti & Company December 2022 Small-Cap Virtual Conference on Wednesday, December 7thDecember 5, 2022 | finance.yahoo.comDelaware Imaging Network Launches the Enhanced Breast Cancer Detection Program, Providing Women a New State-of-the-Art Solution Powered by Artificial IntelligenceNovember 28, 2022 | finance.yahoo.comRadNet’s Aidence Artificial Intelligence (AI) Subsidiary and Google Health Enter into Collaboration to Help Improve Lung Cancer Screening with AI SolutionsNovember 25, 2022 | finance.yahoo.comRadNet, Inc. to Present at the BofA Securities 2022 Leveraged Finance Conference on November 29, 2022November 24, 2022 | finance.yahoo.comRadNet, Inc.'s (NASDAQ:RDNT) Intrinsic Value Is Potentially 72% Above Its Share PriceNovember 9, 2022 | finance.yahoo.comRadNet (RDNT) Misses Q3 Earnings and Revenue EstimatesNovember 9, 2022 | finance.yahoo.comRadNet Forecasts Lower Profits In 2022 Due To Rising Costs, Labor ShortageNovember 7, 2022 | finance.yahoo.comInstitutional owners may consider drastic measures as RadNet, Inc.'s (NASDAQ:RDNT) recent US$130m drop adds to long-term lossesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address RDNT Company Calendar Last Earnings2/28/2023Today3/25/2023Next Earnings (Estimated)5/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:RDNT CUSIPN/A CIK790526 Webwww.radnet.com Phone(310) 445-2800Fax310-445-2980Employees9,067Year Founded1980Price Target and Rating Average Stock Price Forecast$30.00 High Stock Price Forecast$30.00 Low Stock Price Forecast$30.00 Forecasted Upside/Downside+28.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.17 Trailing P/E Ratio137.35 Forward P/E Ratio68.68 P/E GrowthN/ANet Income$10.65 million Net Margins0.74% Pretax Margin3.00% Return on Equity2.64% Return on Assets0.53% Debt Debt-to-Equity Ratio1.71 Current Ratio0.79 Quick Ratio0.79 Sales & Book Value Annual Sales$1.43 billion Price / Sales0.94 Cash Flow$3.55 per share Price / Cash Flow6.57 Book Value$8.57 per share Price / Book2.72Miscellaneous Outstanding Shares57,840,000Free Float54,886,000Market Cap$1.35 billion OptionableOptionable Beta1.55 Social Links Key ExecutivesHoward G. BergerChairman, Co-President & Chief Executive OfficerNorman R. HamesCo-President & COO-Western OperationsStephen M. ForthuberCo-President & COO-Eastern OperationsMark D. StolperChief Financial Officer & Executive Vice PresidentJohn V. CruesMedical Director & Vice PresidentKey CompetitorsVeracyteNASDAQ:VCYTViridian TherapeuticsNASDAQ:VRDNFulgent GeneticsNASDAQ:FLGTCastle BiosciencesNASDAQ:CSTLProgenityNASDAQ:PROGView All CompetitorsInsiders & InstitutionsRockefeller Capital Management L.P.Sold 3,000 shares on 3/6/2023Ownership: 0.309%Robotti RobertSold 1,875 shares on 3/3/2023Ownership: 0.541%Teachers Retirement System of The State of KentuckyBought 2,016 shares on 2/22/2023Ownership: 0.026%State of WyomingSold 1,767 shares on 2/16/2023Ownership: 0.010%Susquehanna Fundamental Investments LLCSold 1,945 shares on 2/15/2023Ownership: 0.033%View All Insider TransactionsView All Institutional Transactions RDNT Stock - Frequently Asked Questions Should I buy or sell RadNet stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RDNT shares. View RDNT analyst ratings or view top-rated stocks. What is RadNet's stock price forecast for 2023? 1 analysts have issued 12 month price targets for RadNet's shares. Their RDNT share price forecasts range from $30.00 to $30.00. On average, they anticipate the company's share price to reach $30.00 in the next year. This suggests a possible upside of 28.5% from the stock's current price. View analysts price targets for RDNT or view top-rated stocks among Wall Street analysts. How have RDNT shares performed in 2023? RadNet's stock was trading at $18.83 at the beginning of 2023. Since then, RDNT shares have increased by 24.0% and is now trading at $23.35. View the best growth stocks for 2023 here. When is RadNet's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023. View our RDNT earnings forecast. How were RadNet's earnings last quarter? RadNet, Inc. (NASDAQ:RDNT) announced its earnings results on Tuesday, February, 28th. The medical research company reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.19 by $0.08. The medical research company had revenue of $383.90 million for the quarter, compared to analyst estimates of $347.27 million. RadNet had a trailing twelve-month return on equity of 2.64% and a net margin of 0.74%. RadNet's revenue for the quarter was up 15.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.13 earnings per share. What ETFs hold RadNet's stock? ETFs with the largest weight of RadNet (NASDAQ:RDNT) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), iShares Micro-Cap ETF (IWC), SPDR S&P 600 Small CapValue ETF (SLYV), iShares U.S. Healthcare Providers ETF (IHF), iShares S&P Small-Cap 600 Value ETF (IJS) and Vanguard S&P Small-Cap 600 Value ETF (VIOV).Invesco S&P SmallCap 600 Equal Weight ETF (EWSC). What guidance has RadNet issued on next quarter's earnings? RadNet updated its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.54 billion-$1.59 billion, compared to the consensus revenue estimate of $1.46 billion. What is Howard G. Berger's approval rating as RadNet's CEO? 174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of RadNet own? Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T). What is RadNet's stock symbol? RadNet trades on the NASDAQ under the ticker symbol "RDNT." Who are RadNet's major shareholders? RadNet's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Beck Mack & Oliver LLC (5.60%), Edmond DE Rothschild Holding S.A. (4.46%), Dimensional Fund Advisors LP (2.68%), Global Alpha Capital Management Ltd. (2.65%), Geode Capital Management LLC (1.63%) and Silvercrest Asset Management Group LLC (1.19%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, John V Crues, Lawrence L Levitt, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson. View institutional ownership trends. How do I buy shares of RadNet? Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is RadNet's stock price today? One share of RDNT stock can currently be purchased for approximately $23.35. How much money does RadNet make? RadNet (NASDAQ:RDNT) has a market capitalization of $1.35 billion and generates $1.43 billion in revenue each year. The medical research company earns $10.65 million in net income (profit) each year or $0.17 on an earnings per share basis. How many employees does RadNet have? The company employs 9,067 workers across the globe. How can I contact RadNet? RadNet's mailing address is 1510 COTNER AVE, LOS ANGELES CA, 90025. The official website for the company is www.radnet.com. The medical research company can be reached via phone at (310) 445-2800, via email at investorrelations@radnet.com, or via fax at 310-445-2980. This page (NASDAQ:RDNT) was last updated on 3/25/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.